CD200 ANTIGEN IN B-CELL DERIVED NEOPLASMS: EXPRESSION AND CLINICAL IMPACT IN 77 CONSECUTIVE PATIENTS OF A SINGLE ISTITUTION
- Autori: Mancuso, S.; Fadda, R.; Bono, R.; Saccullo, G.; Abbadessa, V.; Siragusa, S.
- Anno di pubblicazione: 2012
- Tipologia: Contributo in atti di convegno pubblicato in rivista
- OA Link: http://hdl.handle.net/10447/75031
Abstract
Introduction. CD200 is a cell surface molecule with immune-regulato ry function consistently expressed on lymphoid neoplastic cells. CD200antigen has been found in case studies with a frequency that ranges from 20 % in follicular lymphoma to almost100 % of B-CLL. The interest of CD200 protein from a practical point of view is for its diagnostic and potentially prognostic applications.